Global Viral Vector Manufacturing Market Size is Estimated to Reach USD 1790 million by 2030, Growing at a CAGR of 19.7%: Straits Research
20 déc. 2023 09h20 HE
|
Straits Research
New York, United States, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Molecular biologists use viral vectors to introduce genetic material into cells. To treat genetic disorders, it is used to express and...
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 17.5% by 2034: Visiongain
19 déc. 2023 12h15 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034: Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus,...
Gene Therapy Market to hit USD 44.5 billion by 2032, says Global Market Insights Inc.
07 août 2023 17h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gene Therapy Market size is expected to be worth USD 44.5 billion by 2032. The growing adoption of personalized medicine is generating...
Global Plasmid DNA Manufacturing Market to Surpass US$ 3,733.50 Million by 2030, Says Coherent Market Insights (CMI)
08 févr. 2023 09h00 HE
|
CMI
Burlingame, Feb. 08, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global plasmid DNA manufacturing market is estimated to be valued at US$ 735.67 million in 2022 and is expected...
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
17 janv. 2023 06h00 HE
|
Forecyte Bio
FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet,...
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
23 déc. 2022 06h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market...
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
27 oct. 2022 07h51 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market Segment...
Advent Announces Corporate Name Change to Advaxia
27 sept. 2022 03h00 HE
|
Advaxia
POMEZIA, Italy, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Advent announced today that it is changing its corporate name to Advaxia. The new name reflects the company's evolution, strategic growth and...
Viral Vectors and Plasmid DNA Manufacturing Market Size is projected to reach USD 9.87 Billion by 2030, growing at a CAGR of 14.71%: Straits Research
22 sept. 2022 12h05 HE
|
Straits Research
New York, United States, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Vectors are instruments that are used to carry genetic material into cells, and viral vectors are one such tool. Viruses have developed...
AGC Biologics Supports Altheia Science’s Gene Therapy Programs
28 juil. 2022 08h00 HE
|
AGC Biologics
SEATTLE, MILAN, July 28, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...